×
About 4,778 results

ALLMedicine™ Cardioversion Center

Research & Reviews  2,229 results

Elective cardioversion of atrial fibrillation is safe without transesophageal echocardi...
https://doi.org/10.5603/CJ.a2021.0010
Cardiology Journal; Gorczyca I, Uziębło-Życzkowska B et. al.

Feb 26th, 2021 - Current guidelines recommend electrical cardioversion (ECV) in patients with atrial fibrillation (AF) after at least 3 weeks of adequate non-vitamin K antagonist oral anticoagulant (NOAC) treatment without prior transesophageal echocardiography (T...

Diurnal QT analysis in patients with sotalol after cardioversion of atrial fibrillation.
https://doi.org/10.1111/anec.12834
Annals of Noninvasive Electrocardiology : the Official Jo... Lenhoff H, Darpö B et. al.

Feb 25th, 2021 - The risk of ventricular arrhythmias in patients on QT prolonging drugs is indicated to be increased early after cardioversion (CV) of atrial fibrillation (AF) to sinus rhythm (SR). Sotalol, used to prevent AF relapse, prolongs cardiac repolarizati...

Atrial fibrillation in preterm neonates: A case study.
https://doi.org/10.1016/j.jelectrocard.2021.01.009
Journal of Electrocardiology; Li H, Wei X et. al.

Feb 7th, 2021 - Atrial fibrillation (AF) is rarely found in newborns and infants. It is usually associated with some underlying diseases and presents as tachyarrhythmia. Here, we describe a case of AF in a preterm neonate. Paroxysmal AF and multifocal atrial tach...

Electrocardiographic and Echocardiographic Abnormalities in Patients with Risk Factors ...
https://doi.org/10.1016/j.ccep.2020.10.002
Cardiac Electrophysiology Clinics; Pérez-Riera AR, Barbosa-Barros R et. al.

Jan 31st, 2021 - The electrocardiogram and various echocardiography modalities are important risk markers for atrial fibrillation (AF). Electrocardiographic criteria of left atrial enlargement, advanced interatrial block, and PR-interval prolongation are atrial ri...

Sleep Apnea and Atrial Fibrillation.
https://doi.org/10.1016/j.ccep.2020.10.003
Cardiac Electrophysiology Clinics; Linz D, Nattel S et. al.

Jan 31st, 2021 - Obstructive sleep apnea (OSA) creates a complex and dynamic substrate for atrial fibrillation (AF), which is characterized by structural remodeling as a result of long-term OSA as well as transient and acute apnea-associated transient atrial elect...

see more →

Guidelines  4 results

2018 Focused Update of the Canadian Cardiovascular Society Guidelines for the Managemen...
https://doi.org/10.1016/j.cjca.2018.08.026
The Canadian Journal of Cardiology; Andrade JG, Verma A et. al.

Nov 8th, 2018 - The Canadian Cardiovascular Society (CCS) Atrial Fibrillation Guidelines Committee provides periodic reviews of new data to produce focused updates that address clinically important advances in atrial fibrillation (AF) management. This 2018 Focuse...

2015 ACC/AHA/HRS Advanced Training Statement on Clinical Cardiac Electrophysiology (A R...
https://doi.org/10.1161/HAE.0000000000000014
Circulation. Arrhythmia and Electrophysiology; Zipes DP, Calkins H et. al.

Sep 19th, 2015 - 2015 ACC/AHA/HRS Advanced Training Statement on Clinical Cardiac Electrophysiology (A Revision of the ACC/AHA 2006 Update of the Clinical Competence Statement on Invasive Electrophysiology Studies, Catheter Ablation, and Cardioversion).|2015|Zipes...

How to manage patients on rivaroxaban in the emergency department: a statement of the I...
https://doi.org/10.1097/MEJ.0000000000000322
European Journal of Emergency Medicine : Official Journal... Bernardi E, Carbone G et. al.

Sep 9th, 2015 - Rivaroxaban, a new oral anticoagulant, has been approved in many countries and its everyday use in clinical practice is increasing. Thus, the chances for an emergency physician to encounter rivaroxaban-treated patients in emergency situations have...

European Resuscitation Council Guidelines for Resuscitation 2010 Section 3. Electrical ...
https://doi.org/10.1016/j.resuscitation.2010.08.008
Resuscitation Deakin CD, Nolan JP et. al.

Oct 19th, 2010 - European Resuscitation Council Guidelines for Resuscitation 2010 Section 3. Electrical therapies: automated external defibrillators, defibrillation, cardioversion and pacing.|2010|Deakin CD,Nolan JP,Sunde K,Koster RW,|therapy,methods,standards,ins...

see more →

Clinicaltrials.gov  2,363 results

Elective cardioversion of atrial fibrillation is safe without transesophageal echocardi...
https://doi.org/10.5603/CJ.a2021.0010
Cardiology Journal; Gorczyca I, Uziębło-Życzkowska B et. al.

Feb 26th, 2021 - Current guidelines recommend electrical cardioversion (ECV) in patients with atrial fibrillation (AF) after at least 3 weeks of adequate non-vitamin K antagonist oral anticoagulant (NOAC) treatment without prior transesophageal echocardiography (T...

Diurnal QT analysis in patients with sotalol after cardioversion of atrial fibrillation.
https://doi.org/10.1111/anec.12834
Annals of Noninvasive Electrocardiology : the Official Jo... Lenhoff H, Darpö B et. al.

Feb 25th, 2021 - The risk of ventricular arrhythmias in patients on QT prolonging drugs is indicated to be increased early after cardioversion (CV) of atrial fibrillation (AF) to sinus rhythm (SR). Sotalol, used to prevent AF relapse, prolongs cardiac repolarizati...

Atrial fibrillation in preterm neonates: A case study.
https://doi.org/10.1016/j.jelectrocard.2021.01.009
Journal of Electrocardiology; Li H, Wei X et. al.

Feb 7th, 2021 - Atrial fibrillation (AF) is rarely found in newborns and infants. It is usually associated with some underlying diseases and presents as tachyarrhythmia. Here, we describe a case of AF in a preterm neonate. Paroxysmal AF and multifocal atrial tach...

Electrocardiographic and Echocardiographic Abnormalities in Patients with Risk Factors ...
https://doi.org/10.1016/j.ccep.2020.10.002
Cardiac Electrophysiology Clinics; Pérez-Riera AR, Barbosa-Barros R et. al.

Jan 31st, 2021 - The electrocardiogram and various echocardiography modalities are important risk markers for atrial fibrillation (AF). Electrocardiographic criteria of left atrial enlargement, advanced interatrial block, and PR-interval prolongation are atrial ri...

Sleep Apnea and Atrial Fibrillation.
https://doi.org/10.1016/j.ccep.2020.10.003
Cardiac Electrophysiology Clinics; Linz D, Nattel S et. al.

Jan 31st, 2021 - Obstructive sleep apnea (OSA) creates a complex and dynamic substrate for atrial fibrillation (AF), which is characterized by structural remodeling as a result of long-term OSA as well as transient and acute apnea-associated transient atrial elect...

see more →

News  181 results

EARLY AF and STOP AF Put Electrophysiology at a Crossroads
https://www.staging.medscape.com/viewarticle/941098

Nov 16th, 2020 - Two studies published in the New England Journal of Medicine compare ablation to antiarrhythmic drugs early in the course of atrial fibrillation (AF). Their "positive" results scare me; AF ablation is already overused. Both the U.S. STOP AF trial ...

Fast Five Quiz: Clinical Management of Atrial Fibrillation
https://reference.staging.medscape.com/viewarticle/924961_4

Apr 1st, 2020 - Anticoagulation for nonvalvular AF is managed with one of the DOAC agents. Currently available DOAC agents include factor Xa inhibitors (apixaban, edoxaban, or rivaroxaban) and the direct thrombin inhibitor dabigatran. DOAC agents can be initiated...

Competing Strategies Rapidly Restore Sinus Rhythm in Acute AF
https://www.medscape.com/viewarticle/925156

Feb 11th, 2020 - Randomized data provide equal support for pharmacological and electrical cardioversion of acute atrial fibrillation (AF), but also point to a potential advantage for the drug-first strategy in younger patients and those with first AF episodes. Con...

Dec 13, 2019 This Week in Cardiology Podcast
https://www.medscape.com/viewarticle/922528

Dec 12th, 2019 - For the week ending Dec 13, 2019 John Mandrola, MD, comments on the following cardiology news stories: EXCEL Leaders Answer Back After BBC Exposé European Left Main Guidelines in Disarray After EXCEL Cover-up Alleged FDA Panel Rejects Vernakalant ...

FDA panel rejects vernakalant bid for AFib cardioversion indication
https://www.mdedge.com/jcomjournal/article/214099/arrhythmias-ep/fda-panel-rejects-vernakalant-bid-afib-cardioversion?channel=37225
Steve Stiles

Dec 11th, 2019 - A Food and Drug Administration advisory committee has voted 11 to 2 against a recommendation that the agency approve a long-studied antiarrhythmic agent for cardioversion of recent-onset atrial fibrillation (AFib). It was the second time before an.

see more →

Patient Education  1 results see all →